# Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia

> **NCT00197483** · — · SUSPENDED · sponsor: **Hamamatsu University** · enrollment: 20 (—)

## Conditions studied

- Schizophrenia
- Negative Symptoms
- Cognitive Impairments

## Interventions

- **DRUG:** Pergolide (drug)

## Key facts

- **NCT ID:** NCT00197483
- **Lead sponsor:** Hamamatsu University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** SUSPENDED
- **Start date:** 2003-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 20 (—)
- **Last updated:** 2005-09-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00197483

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00197483, "Effective Adjunctive Use of Pergolide for Cognitive Impairment and Negative Symptoms in Schizophrenia". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00197483. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*